SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Smruthi Organics - Quaterly Results

04 Feb 2025 Evaluate
A decent increase of about 33.09% in the sales to Rs. 312.50 millions was observed for the quarter ended December 2024. The sales figure stood at Rs. 234.81 millions during the year-ago period.The Total Profit for the quarter ended December 2024 of Rs. 14.82 millions grew from Rs.-22.92 millions Operating profit Margin for the quarter ended December 2024 improved to 41.68% as compared to -11.77% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 312.50 234.81 33.09 879.14 879.85 -0.08 1276.43 1410.41 -9.50
Other Income 0.04 0.02 100.00 0.13 0.15 -13.33 0.76 1.07 -28.97
PBIDT 41.68 -11.77 -454.12 75.18 78.86 -4.67 120.31 98.87 21.69
Interest 5.08 3.19 59.25 13.54 10.36 30.69 14.08 8.22 71.29
PBDT 36.60 -14.96 -344.65 61.64 68.50 -10.01 106.23 90.65 17.19
Depreciation 13.70 14.52 -5.65 39.97 40.66 -1.70 56.53 45.72 23.64
PBT 22.90 -29.48 -177.68 21.67 27.84 -22.16 49.70 44.93 10.62
TAX 8.08 -6.56 -223.17 8.32 7.12 16.85 13.79 3.63 279.89
Deferred Tax 0.40 -0.23 -273.91 -0.52 -2.26 -76.99 -2.27 -10.97 -79.31
PAT 14.82 -22.92 -164.66 13.35 20.72 -35.57 35.91 41.30 -13.05
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 13.34 -5.01 -366.08 8.55 8.96 -4.59 9.43 7.01 34.46

Smruthi Organics Share Price

112.94 -2.15 (-1.87%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×